Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 62 pseudogene (RNU7-62P) is classified as a **pseudogene** corresponding to a small nuclear RNA (snRNA) known for its broader family’s role in mRNA processing, specifically histone pre-mRNA 3' end formation[1][5][6][8]. This pseudogene does not encode a functional product and is not itself part of any characterized biological pathway, does not serve as a receptor, enzyme, or transporter, and is not considered a therapeutic target. The canonical (functional) related gene, RNU7-1 (RNA, U7 small nuclear 1), is responsible for forming the U7 snRNP complex, which is essential in histone mRNA processing[2][3][4][5]. However, as a pseudogene, RNU7-62P is generally transcribed inefficiently or not at all, does not perform these functions, and has no known disease associations or characterized biological implications[1][6][7]. In summary, RNU7-62P is a nonfunctional copy (pseudogene) of the U7 small nuclear RNA gene family and not a bona fide molecular or therapeutic target[1][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 62 pseudogene (RNU7-62P).